Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

March 2, 2020 at 8:30 AM EST

BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences:

  • Cowen 40th Annual Health Care Conference
    Presentation Date: Wednesday, March 4th at 10:00 a.m. Eastern Time
    Location: Boston, MA
  • Barclays Global Healthcare Conference
    Presentation Date: Wednesday, March 11th at 8:30 a.m. Eastern Time
    Location: Miami, FL

Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will also be available on the Sangamo website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation. For more information about Sangamo, visit www.sangamo.com.

Investor Relations – Global
McDavid Stilwell
510-970-6000, x219
mstilwell@sangamo.com

Media Inquiries – Global
Aron Feingold
510-970-6000, x421
afeingold@sangamo.com

Source: Sangamo Therapeutics, Inc.